A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers

Overview of attention for article published in Clinical Epigenetics, June 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs: 1 blog
twitter: 7 X users

patent: 1 patent

Citations

dimensions_citation: 139 Dimensions

Readers on

mendeley: 198 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPIES COMPRISING A HYPOMETHYLATION AGENT FOR TREATING CANCER

Application WO-2021247430-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.